Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00776126 · ClinicalTrials.gov registry record

Digital Breast Tomosynthesis Preference Study

A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
51
Enrollment target

NCT00776126: Completed study, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT00776126 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00776126 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

Mammography remains the current standard in the detection of breast cancer. However, conventional two-view mammography will not detect all cancers. The major limiting factor of conventional mammography is the presence of superimposed breast tissue that can obscure clinically significant lesions. It is this limitation that decreases the sensitivity of mammography and leads to false negative results. The recent development of digital detectors has allowed imaging technologies such as tomosynthesis to become clinically feasible. The examination, similar to conventional mammography with regard to patient positioning and glandular dose, allows acquisition of a digital data set that can be reconstructed and viewed in multiple sections. The ability of tomosynthesis to unmask overlapping structures has been shown in preliminary studies to increase lesion visibility. Used as either a primary imaging modality, or as an adjunct to screening mammography, tomosynthesis has the potential to provide increased sensitivity and a lower number of false negative examinations. The purpose of this study is to compare radiologist impression of digital breast tomosynthesis to digital mammography with respect to their ability to see and characterize specific lesion features.

Interventions

  • DEVICE Digital Breast Tomosynthesis Exam

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2008-10
Est. Completion 2010-06

What the finished NCT00776126 record still lists

NCT00776126 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Digital Breast Tomosynthesis Exam is the first listed.

NCT00776126 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00776126 about?

NCT00776126 is a clinical study titled "Digital Breast Tomosynthesis Preference Study". Mammography remains the current standard in the detection of breast cancer. However, conventional two-view mammography will not detect all cancers. The major limiting factor of conventional mammography is the presence of superimposed breast tissue that can obscure clinically significant lesions. It ...

What is the current status of trial NCT00776126?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2008-10. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00776126?

The interventions under investigation include: Digital Breast Tomosynthesis Exam (DEVICE).

Who is sponsoring clinical trial NCT00776126?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00776126, the US trial registry maintained by the National Library of Medicine. NCT00776126 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.